Richard Hague, Chief Commercial Officer at Anika Therapeutics, Inc. (ANIK), sold 5,250 shares at $54.48 ($286K) on 2017-11-30, disclosed to the SEC on 2017-12-01.
Open-market sale of $286k ANIK by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| PTE | SELL | 2021-07-01 | $6K | — | Filing → |
| PTE | SELL | 2020-02-07 | $39K | — | Filing → |
| PTE | SELL | 2019-10-30 | $6K | — | Filing → |